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Objective: The ABCA2 transporter shares high structural homology to ABCA1, which is crucial for the
removal of excess cholesterol from macrophages and, by extension, in atherosclerosis. It has been sug-
gested that ABCA2 sequesters cholesterol inside the lysosomes, however, little is known of the
macrophage-specific role of ABCA2 in regulating lipid homeostasis in vivo and in modulating suscepti-
bility to atherosclerosis.
Methods: Chimeras with dysfunctional macrophage ABCA2 were generated by transplantation of bone
marrow from ABCA2 knockout (KO) mice into irradiated LDL receptor (LDLr) KO mice.
Results: Interestingly, lack of ABCA2 in macrophages resulted in a diminished lesion size in the aortic root
(24.5%) and descending thoracic aorta (36.6%) associated with a 3-fold increase in apoptotic cells, as
measured by both caspase 3 and TUNEL. Upon oxidized LDL exposure, macrophages from wildtype (WT)
transplanted animals developed filipin-positive droplets in lysosomal-like compartments, corresponding
to free cholesterol (FC) accumulation. In contrast, ABCA2-deficient macrophages displayed an abnormal
diffuse distribution of FC over peripheral regions. The accumulation of neutral sterols in lipid droplets
was increased in ABCA2-deficient macrophages, but primarily in cytoplasmic clusters and not in lyso-
somes. Importantly, apoptosis of oxLDL loaded macrophages lacking ABCA2 was increased 2.7-fold,
probably as a consequence of the broad cellular distribution of FC.
Conclusions: Lack of functional ABCA2 generates abnormalities in intracellular lipid distribution/traf-
ficking in macrophages consistent with its lysosomal sequestering role, leading to an increased
susceptibility to apoptosis in response to oxidized lipids and reduced atherosclerotic lesion development.
 2012 Elsevier Ireland Ltd. Open access under the Elsevier OA license.1. Introduction
The excessive accumulation of cholesterol in macrophages can
lead to their transformation into foam cells contributing to the
initiation and progression of atherosclerotic lesions. ATP-Binding
Cassette (ABC) transporters constitute a large highly conserved
superfamily of membrane molecules that use the energy of ATPeberdiell@lacdr.leidenuniv.nl
der the Elsevier OA license.hydrolysis to transport a wide variety of substrates across the cell
membrane [1]. To date, there are 52 characterized human ABC
transporter genes, which can be divided into seven classes (AeG),
and mutations in these genes cause several human genetic
disorders [1]. Several ABC transporters exert major functions in
macrophage lipid and lipoprotein trafficking being intimately
involved in the pathogenesis of atherosclerosis [2,3]. In this
context, ABCA1 has a particularly important role in mediating
cholesterol and phospholipid efflux from macrophages in the
presence of apolipoprotein (apo) acceptors like apoAeI [4]. Apart
from ABCA1, other members of the ABC transporter superfamily
play a significant role in protection against atherosclerosis by
L. Calpe-Berdiel et al. / Atherosclerosis 223 (2012) 332e341 333facilitating the removal of excess cholesterol from macrophages,
such as ABCG1 and ABCB4 [5,6].
ABCA2 is a full-size ABC transporter of 270 kDa which is located
on chromosome 9q close to ABCA1 [7,8]. Bothmembers share a high
degree of structural homology, strongly suggesting a duplication
event during evolution [9]. Analysis of the ABCA2 promoter region
exposed multiple potential binding sites for transcription factors
with potential roles in the differentiation and activation of macro-
phages,myeloid andneural cells [7,10,11].Moreover, ABCA2 contains
promoter target sites for SP1, a transactivator which can modulate
the promoter activity of the cholesterol-responsive transporter
ABCA1 and half-size transporter ABCG1 [7], as well as the presence
of a lipocalin signature motif coding a conserved group of proteins
which bind and transport sterols [12,13]. It is thus conceivable that
ABCA2, like ABCA1, can function as a facilitator of cholesterol lateral
translocation. In fact, it was reported that ABCA2 is involved in the
intracellular metabolism of sphingolipids in the brain andmay serve
as a regulator of cholesterol and phospholipid flux to the myelin
membrane in oligodendrocytes [14,15]. ABCA2 is detected in endo-
somes, lysosomes and trans-Golgi network organelles. It is found
predominantly in the brain and to a lesser extent in kidney, uterus,
liver, heart, thymus, and myeloid cells, including monocytes
[7,9,12,16]. Interestingly, ABCA2 expression is upregulated during
monocyte differentiation into macrophages [19].
ABCA2 is a sterol-sensitive gene which is overexpressed by
sustained cholesterol influx in the presence of enzymatically
modified LDL in macrophages [7], showing a regulatory response
similar to transporters ABCA1 and ABCG1 [17,18]. A functional role
for the ABCA2 transporter in the intracellular cholesterol traf-
ficking, delivering low-density lipoprotein (LDL)-derived free
cholesterol (FC) to the endoplasmic reticulum for esterification, has
been described in Chinese hamster ovary (CHO) cells and neuro-
blastoma cells [19e21]. Stable overexpression of ABCA2 in CHO
cells showed cholesterol sequestration in lysosomes and positively
regulated other genes that increase cellular cholesterol levels (LDL
receptor (LDLr) and 3-hydroxy-3-methylglutaryl CoA synthase
(HMGCoA S)) whereas it reduced the esterification of LDL-derived
FC [19]. Recently, ABCA2 was shown to regulate cholesterol
homeostasis and LDLr metabolism in neuronal-type-like cells [21].
Given the importance of cholesterol homeostasis inmacrophages
for prevention of foam cell formation and the anti-atherogenic
effects of leukocyte ABCA1 in hyperlipidemic mice [22,23], ABCA2
represents a potentially attractive target for atherosclerosis inter-
vention. The data presented in the current study provide, to our
knowledge, the first assessment of the effect of hematopoietic
ABCA2 deficiency on atherosclerosis and lipid metabolism in mice
using the bone marrow (BM) transplantation strategy.
2. Methods
An expanded Methods section is available in the data
supplement.
2.1. Animals
ABCA2 knockout (KO) and ABCA2 wildtype (WT) mice were
bred and maintained as previously described [15]. Homozygous
LDLr KO mice were obtained from The Jackson Laboratory (Bar
Harbor, Me) as mating pairs and bred at the Gorlaeus Laboratory
(Leiden, The Netherlands).
2.2. Bone marrow transplantation
To induce bonemarrow aplasia, LDLr KO recipientmice of 10e12
weeks old were exposed to a single dose of 9 Gy 1 day before thetransplantation (n ¼ 13e14 per group). Bone marrow was isolated
from the donor ABCA2 KO and WT mice with phosphate-buffered
saline (PBS). Irradiated recipients received 5  106 bone marrow
cells by intravenous injection into the tail vein.
2.3. Serum lipid and lipoprotein analyses
The concentrations of total cholesterol (TC), phospholipids (PL)
and triglycerides (TG) in serum were determined using enzymatic
colorimetric assays Absorbance was read at 490 nm. The distribu-
tion of lipids over the different lipoproteins in serum was deter-
mined by fractionation of 30 mL serum of each mouse using
a Superose 6 column. After 10 weeksWTD feeding, total blood cells
were quantified using an automated Sysmex XT-2000iV analyzer
(Goffin Meyvis, Etten-Leur, The Netherlands).
2.4. Flow cytometry analysis
After sacrificing the mice, spleen, liver, and peritoneal macro-
phages were isolated and single cell suspensions were obtained.
Subsequently, 300,000 cells were stained with the appropriate
antibodies.
2.5. Lipoprotein isolation and generation of bone marrow-derived
macrophages in vitro
Please see Supplementary methods.
2.6. Gene mRNA and protein expression analysis
Quantitative gene expression analysis was performed using the
SYBR-Green method on an Applied Biosystems Prism 7500
sequence detection system (Applied Biosystems, Foster City, CA).
PCR primers (Supplemental Table 1) were designed using Primer
Express Software according to the manufacturer’s default settings.
Immunoblotting on protein from peritoneal macrophages was
performed as described previously [24].
2.7. Foam cell formation studies
BM-derived macrophages were incubated with oxLDL
(20 mg/mL) for 24 h. Lipid accumulation was visualized with
Oil-red O staining. Cellular lipids were extracted with isopropyl
alcohol-hexane (2:3 v/v), dried with nitrogen and reconstituted
with isopropyl alcohole0.5% sodium cholate [25], as previously
described. Shingomyelin species were analyzed using liquid
chromatography/mass spectrometry methodology.
For analysis of in vivo foam cell formation, on sacrifice the
peritoneal cavity of the mice was lavaged with 10 mL cold PBS to
collect peritoneal leukocytes for quantification of macrophage foam
cells. Samples were cytospun and stained with Oil-red O for
detection of lipid accumulation.
2.8. Histological analysis of the aortic root and tissues
Cryosections of formalin-fixed lung, liver, brain and spleen from
ABCA2 KO andWT transplanted animals were prepared and stained
for lipid accumulation using Oil-red O staining. Hematoxylin
(Sigma Diagnostics, St. Louis, MO, USA) was used to stain the nuclei
in the different organs. Atherosclerotic mean lesion area (in mm2)
was quantified in the aortic root from tenOil-red O-stained sections
for each animal, starting at the appearance of the tricuspid valves,
as well as in the thoracic descending aorta and the aortic arches.
Themacrophage infiltration, the collagen content and the apoptotic
cells in the atherosclerotic lesions were determined.
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against murine ABCA2, and silencing effect of pSUPER-H1.shABCA2
A pair of 64-nucleotide shRNA oligonucleotides which con-
tained extra BglII and HindIII restriction sites to facilitate cloning,
was designed targeting murine ABCA2. The 64-nucleotide oligo-
nucleotides were annealed and cloned into de BglII and HindIII sites
of the pSUPER vector. The lentiviral expression vectors pRR1-cPPt-
H1.PreSIN (H1.Empty) and pRR1-cPPt-H1.shABCA2-PreSIN
(H1.shABCA2) were constructed by removing the cytomegalovirus
(CMV) promoter from the expression vector pRR1-cPPt-CMV.Pre-
SIN using ClaI and PstI digestion, followed by insertion of the H1
promoter or the complete H1.shABCA2 construct. Target cells (thi-
oglycollate-elicited peritoneal macrophages) were transiently
cotransfected with either H1.Empty or H1.shABCA2 lentivirus
vectors (MOI 15) using Lipofectamine 2000 (Invitrogen). After 24 h,
quantitative analysis of ABCA2 expression was determined.
2.10. Macrophage cholesterol efflux studies
Wild-type (C57BL/6) and ABCA1 KO (with a C57BL/6 back-
ground) thioglycollate-elicited peritoneal macrophages were
transiently cotransfected with either H1.Empty or H1.shABCA2
lentivirus vectors (MOI 15) for 24 h. Subsequently, cells were
incubated with oxLDL/0.5 mCi/mL 3H-cholesterol in DMEM/0.2%
BSA (fatty acid free) for 24 h at 37 C. Cholesterol efflux was studied
by incubation of the cells with DMEM/0.2% BSA alone or supple-
mented with either 10 mg/mL apo-AI (Calbiochem) or 50 mg/mL
human HDL.
2.11. Fluorescence microscopy
WT and ABCA2 KO BM-derived macrophages were seeded in
control medium or supplemented with oxLDL (20 mg/mL) for 24 h.
After treatment FC, neutral sterols and PL distribution were
detected with lipidTOX according to the manufacturers protocol
(Invitrogen, Carlsbad, CA, USA). Cleaved caspase 3 antibody
detecting endogenous levels of the large fragment of activated
caspase 3 resulting from cleavage adjacent to Asp175was used (Cell
Signalling Technology, The Netherlands). Image acquisition was
performed using a Nikon TE2000 combined with a Prior stage. All
images were processed and quantitative image analysis was per-
formed using Image-Pro Plus (Version 5.1; Media Cybernetics).
2.12. Transmission electron microscopy
For electron microscopy, WT and ABCA2 KO BM-derived
macrophages were plated in control medium or supplemented
with oxLDL (20 mg/mL) for 24 h. Subsequently, cells were fixed and
embedded in an epoxy resin. Ultrathin sections were post stained
with uranyl acetate and lead citrate and viewed and imagedwith an
FEI Tecnai 12 transmission electron microscope, operated at 120 kV
and equipped with an Eagle 4kx4k camera (FEI, Eindhoven, The
Netherlands).
2.13. Data analyses
Data are expressed as mean S.E.M. Comparison of data for two
groups was performed by Student’s t-test or ManneWhitney U test,
depending onwhether the distribution of datawas Gaussian or not.
To compare differences among groups One-way ANOVA with
NewmaneKeuls post-test was performed using GraphPad Prism
version 4.00 for Windows (GraphPad Software, San Diego, CA, USA,
www.graphpad.com). A P value <0.05 was considered statistically
significant.3. Results
3.1. Effect of macrophage ABCA2 deficiency on serum lipid levels
and circulating cells in LDLr KO mice
ABCA2 was selectively disrupted in hematopoietic cells, thus
including macrophages, by transplantation of BM from ABCA2 KO
mice into LDLr KO mice, which represent a recognized model for
the development of atherosclerosis. After a recovery period of 8
weeks on regular murine chow diet, the transplanted mice were
challenged with a high cholesterol, high fat WTD for 10 weeks.
During the course of the experiment, the weight gain curve was
unaffected between ABCA2 KO and WT mice (data not shown).
On regular chow diet, serum TC, TG, and PL levels were similar
between WT and ABCA2 KO transplanted mice (Supplemental
Fig. IA). Furthermore, the distribution of lipids over the different
lipoprotein fractions of both experimental groups was essentially
the same. Switching from a regular chow diet to a WTD resulted in
an approximately 2.3-fold increase in serum TC levels in both types
of chimeric mice (Supplemental Fig. IB). After 10 weeks WTD
feeding, no significant effect of macrophage ABCA2 deficiency was
observed on serum TC levels (828  89 mg/dL vs. 1008  88 mg/dL
in WT transplanted mice; P ¼ 0.16), TG (142  10 mg/dL vs.
150  13 mg/dL in transplanted WT mice; P ¼ 0.61) or PL
(793  79 mg/dL vs. 727  34 mg/dL in transplanted WT mice;
P ¼ 0.47). Fractionation of serum lipoproteins for TC (Supplemental
Fig. I), TG and PL (data not shown) did not show significant changes
in lipoprotein distribution patterns between groups.
Bone marrow ABCA2-deficiency did not result in changes in the
number of circulating blood cells (Supplemental Fig. II). Thus,
ABCA2 KO chimera mice showed similar counts than WT trans-
planted mice for total leukocytes (1.8  0.2  109 cells/L vs.
1.4  0.2  109 cells/L), neutrophils (0.6  0.1  109 cells/L vs.
0.4  0.1  109 cells/L), lymphocytes (1.1  0.1  109 cells/L vs.
0.8  0.1  109 cells/L) and monocytes (0.1  0.04  109 cells/L vs.
0.1  0.02  109 cells/L).3.2. Effect of macrophage ABCA2 deficiency on immune cells and
lipid homeostasis in tissues
No morphological changes in tissues rich in macrophages, such
as liver, spleen, lung and brain, were observed in ABCA2 KO
transplanted animals compared to their control littermates.
Accordingly, no differences in tissue weight were found as
a consequence of leukocyte ABCA2 deficiency (data not shown).
This fact was consistent with the similar extent of neutral lipid
accumulation between ABCA2 KO and WT transplanted mice
visualized, as indicated by Oil-red O staining (Supplemental
Fig. IIIAeD) and confirmed by extracting hepatic lipids with
organic solvents (Supplemental Fig. IIIE). No inflammation was
observed in the liver. In line, the expression of CD68, TNF-a, and IL-
6 was not changed (Supplementary Fig. IIIF). In light of the
predominant expression of ABCA2 in myeloid cell types, it is
conceivable that this transporter is involved in processes associated
with immune functions. The effect of macrophage ABCA2 defi-
ciency on cellular composition in liver, spleen and peritoneal cells
was measured by flow cytometry (Supplemental Fig. IV). Overall,
the loss of function of macrophage ABCA2 did not modify the
percentage of the cell subsets studied. However, there was a slight
increase in the percentage values of CD4þ and CD8þ lymphocytes in
spleens of animals which were transplanted with BM deficient for
the ABCA2 transporter (30.8  1.2% vs. 25.9  1.6% in WT trans-
planted mice; P ¼ 0.04 and 15.0  0.8% vs. 12.7  0.6% in trans-



























































































Fig. 1. Effect of macrophage ABCA2 deficiency on in vivo foam cell formation of LDLr KO
mice reconstituted withWTand ABCA2 KO bonemarrow. (A) Peritoneal leukocytes from
transplanted mice were analyzed using a hematology analyzer and the number of
macrophage foam cells was quantified as percentage of the total amount of isolated cells.
Values represent themeanSEMof13micepergroup. (B)TotalRNA fromcells andABCA1
mRNA expression was determined by real-time RT-PCR. HPRT, b-actin and GAPDH were
used as the standard housekeeping genes. Values represent themean SEMof 4e6mice
per group. (C) Western blots showing ABCA1 protein in cell lysates of WT and ABCA2 KO
peritonealmacrophages. Equal amounts of cellular protein extractswere loaded on a 7.5%
SDS-PAGE gel. A single band of ABCA1 protein (w230 kDa) was detected with different
abundance in all tested samples. b-actin (w40 kDa) was used to control equal loading.
Statistically significant difference *P < 0.05.
L. Calpe-Berdiel et al. / Atherosclerosis 223 (2012) 332e341 335was observed for the total CD3þ lymphocyte population count
(Supplemental Fig. IVB).
3.3. Effect of macrophage ABCA2 deficiency on in vivo foam cell
formation and atherosclerosis
The transformation of macrophages into foam cells upon lipid
loading is considered a crucial process in the formation of athero-
sclerotic lesions. Therefore, to investigate whether disruption of
ABCA2 in macrophages would affect foam cell formation, resident
peritoneal leukocytes were isolated from mice transplanted with
WTand ABCA2 KO bonemarrow after 10weeksWTD feeding. Foam
cell counts did not significantly differ between both experimental
groups (0.3  0.04% vs. 0.3  0.05% in WT transplanted mice;
P ¼ 0.43) (Fig. 1A). Microscopic visualization using Oil-red O-
stained cytospins, as well as the intracellular lipid content did not
show significant changes (data not shown). Interestingly, themRNA
expression of ABCA1 was 1.3-fold (P ¼ 0.036) upregulated in the
ABCA2 KO group (Fig. 1B). In line, Western-blot analysis showed
a 1.9-fold increase (P ¼ 0.04) in ABCA1 protein expression in the
ABCA2 KO macrophages as compared to WT cells (Fig. 1C).
Next, the susceptibility to atherosclerosis in the aortic root and
thoracic aorta of LDLr KOmice reconstitutedwithWTandABCA2 KO
bone marrow after 10 weeks WTD feeding was analyzed (Fig. 2).
Dissection of the descending thoracic aorta and the aortic arch and
en face examination showed less Oil-red O staining in the ABCA2 KO
transplanted group (36.6%) as compared to the WT transplanted
controls (3.8  0.4% and 6.0  1.1% respectively, P < 0.05) (Fig. 2D
and E). In line with the findings in the descending aorta, lack of
ABCA2 in macrophages resulted in a diminished (24.5%) mean
atherosclerotic lesion size in the aortic root (163140 19786 mm2 vs.
216,143  20482 mm2 in WT transplanted mice; P < 0.05)(Fig. 2A).
Because the composition of atherosclerotic lesions, along with
lesion size, is critically important in atherogenesis, cell and matrix
components of the lesions were also characterized by analyzing
macrophage content and collagen deposition (Fig. 2B and C).
Macrophage ABCA2 deficiency did not affect atherosclerotic lesion
composition (the macrophage content: 39.4  2.4% vs. 39.3  2.2%
in WT transplanted mice; the collagen content: 8.0  0.7% vs.
7.9  0.8% in WT transplanted mice). To determine apoptosis,
atherosclerotic lesions from both groups of animals were stained for
caspase 3 activity. The data in Fig. 3A demonstrate unequivocally
that lesions in the aortic roots of ABCA2 KO transplanted mice dis-
played a 3-fold increase in cleaved caspase 3-positive apoptotic cells
as compared with mice receiving WT bone marrow (P ¼ 0.007),
while also the percentage of TUNEL positive cells in lesions was also
significantly increased (Supplementary data V).
3.4. Effect of ABCA2 deficiency on macrophage apoptosis
susceptibility
To investigate whether the increase in apoptotic cells observed
in lesions of LDLr KO mice transplanted with ABCA2 KO bone
marrowwas amacrophage-intrinsic response, BMDM fromWTand
ABCA2 KO mice were loaded in the presence of oxLDL, the prom-
inent lipoprotein present in atheromas, for 24 h (Fig. 3B). Inter-
estingly, there was a 2.7-fold increase in the number of ABCA2 KO
cells undergoing apoptosis as compared with WT macrophages
(36.3  1.9 vs. 13.35  3.5; P < 0.001).
3.5. Effect of macrophage ABCA2 deficiency on efflux of free
cholesterol
In the absence of macrophage ABCA2, the expression of the
crucial lipid efflux transporter ABCA1 was upregulated inperitoneal macrophages, possibly to compensate for the loss of
function of ABCA2. In order to reveal the intrinsic role of ABCA2 on
cellular efflux of free cholesterol an approach using lentiviral
vectors to reduce ABCA2 expression in ABCA1-deficient macro-
phages was carried out to minimize the ABCA1-dependent effect.
Knockdown of ABCA2 was achieved by means of lentiviral






















































































































































































Fig. 2. Effect of macrophage ABCA2 deficiency on atherosclerotic lesion development and composition in the aortic root and the descending thoracic aorta of LDLr KO mice
reconstituted with WT and ABCA2 KO bone marrow after 10 weeks on WTD. (A) The mean lesion area was calculated from Oil-red O-stained cross-sections of the aortic root at the
level of the tricuspid valves (original magnification 50). (B) Macrophage content measured by a MOMA2 staining (original magnification 50), (C) collagen content measured by
a Masson’s Trichrome staining (original magnification 50). Representative photomicrographs are shown in all cases. Values represent the mean  SEM of 12e13 mice per group.
(D) Representative Oil-red O-stained thoracic aortas and the aortic arch from LDLr KO mice reconstituted with WT (top) and ABCA2 KO (bottom) BM after 10 weeks on WTD.
(E) Percent thoracic aorta and the aortic arch surface area occupied by plaque. Values represent the mean  SEM of 7e8 mice per group. Statistically significant difference *P < 0.05.
L. Calpe-Berdiel et al. / Atherosclerosis 223 (2012) 332e341336peritoneal macrophages. A 79% decrease in ABCA2 expression was
found in WT H1.shABCA2-transfected cells (referred as ABCA2
knockdown (KD) macrophages)(P ¼ 0.0015), whereas an 80%
decline was observed in ABCA1 KO H1.shABCA2-transfected cells
(referred as the ABCA1 KO/A2 KD group)(P ¼ 0.0016), both
compared to WT macrophages (WT H1.Empty-transfected cells).
ABCA1 mRNA expression was w1.7-fold increased upon knock-
down of ABCA2 in WT macrophages (ABCA2 KD vs. WT macro-
phages; P ¼ 0.0014). No effects on ABCG1 expression were found
(data not shown).
Secondly, the percentage of 3H-cholesterol efflux from oxLDL-
laden WT, ABCA1 KO, ABCA2 KD and ABCA1 KO/A2 KD peritonealmacrophages to humanHDL did not differ significantly between the
experimental groups (Supplemental Fig. VI). However, a marked
reduction in cholesterol efflux was observed from ABCA1 KO and
ABCA1 KO/A2 KD macrophages when using apo-AI as exogenous
lipid acceptor (1.2  0.1% and 1.1  0.2% vs. 4.5  1.1% in WT
macrophages, respectively; P < 0.05). Efflux to apo-AI from ABCA2
KD macrophages was not modified when compared to WT cells
(3.4  0.6% and 4.5  1.1%, respectively; P ¼ 0.4). Importantly, the
increased apoptosis susceptibility of macrophages lacking ABCA2 is
thus probably not the consequence of increased FC accumulation in
the cell as a result of impaired cholesterol efflux. In agreement,
cellular FC concentrations were unaffected by macrophage ABCA2
Fig. 3. Effect of macrophage ABCA2 deficiency on apoptosis in vivo and in vitro. (A) Sections of aortic roots of WT and ABCA2 KO transplanted animals (n ¼ 8/genotype) were
immunostained for the presence of apoptotic cells with cleaved caspase 3 (original magnification 200). (B) Fluorescence photomicrographs of cleaved caspase 3-stained WT and
ABCA2 KO BMDM cultured in the presence of oxLDL (20 mg/mL) for 24 h, and graphs show the quantitation of the image analysis of random fields (percent of apoptotic-positive
cells). Values represent the mean  SEM. Statistically significant difference **P < 0.01, ***P < 0.001. Bar, 10 mm.
L. Calpe-Berdiel et al. / Atherosclerosis 223 (2012) 332e341 337deficiency upon oxLDL loading (FC: 255.2  85.95 mg/ng vs.
296.4  48.91 mg/ng in WT transplanted mice) (Supplemental
Fig. VIIA). In addition, no differences were found in the content of
neutral sterols (CE: 226.8  54.96 mg/ng vs. 199.4 31.24 mg/ng and
TG: 24.5  11.08 mg/ng vs. 26.28  18.92 mg/ng in WT transplanted
mice, respectively) and phospholipids (PL: 225.2  81.97 mg/ng vs.
274.0  33.41 mg/ng in WT transplanted mice).
3.6. Effect of macrophage ABCA2 deficiency on intracellular
macrophage cholesterol metabolism
To gain further insight into the impact of ABCA2 expression on
macrophage cholesterol homeostasis, intracellular cholesterol
metabolism was studied in more detail. Hereto, the genes expres-
sion of key genes in cholesterol metabolism was assessed in BM-
derived macrophages upon oxLDL exposure. As expected, deletion
of macrophage ABCA2 in oxLDL-laden macrophages resulted in
a complete absence of ABCA2 mRNA (Supplemental Fig. VIIB).
Potential compensatory expression of other ABCA transporters in
KO cells was examined by quantitative real-time RT-PCR analysis. In
basal media conditions, in line with previous data, a w1.5-fold
upregulation of ABCA1 mRNA expression was found in ABCA2 KO
macrophages (data not shown), similarly as in peritoneal macro-
phages (Fig. 1B), which was even more accentuated upon oxLDL
exposure (w3-fold; P¼ 0.046) (Supplemental Fig. VIIB). In addition,
oxLDL-stimulated ABCA2 KO macrophages showed a down-
regulation of HMG-CoA reductase (w1.7-fold; P ¼ 0.03) and Sp1
transcription factor (2-fold; P ¼ 0.02), and an upregulation of CD36
scavenger receptor (w1.7-fold; P < 0.001).Next, fluorescent microscopy was employed to examine the
distribution of lipids within the cells. Interestingly, noticeable
differences were apparent between WT and ABCA2 KO macro-
phages in lipid distribution pattern, both in control media and after
incubation with oxLDL. WT cells showed bright FC clusters,
whereas ABCA2-deficient foam cells mainly displayed a diffuse
distribution of FC with significantly reduced number of vesicles per
nuclei in both control (11.8-fold less) and oxLDL loading (2-fold
less) conditions (Fig. 4A). Furthermore, under the same experi-
mental settings, ABCA2 KO cells exhibited more numerous neutral
sterol lipid droplets as compared to WT macrophages (Fig. 4B)(3-
fold for control and 2.3-fold for oxLDL exposure). No difference in
the PL pattern between lipid-laden WT and ABCA2 KO was
observed, although, as previously described [26,27], oxLDL induced
phospholipidiosis in macrophages (Fig. 4B insets). Exactly the same
observations for FC, neutral sterols and PL distribution were found
when methyl-beta-cyclodextrin, which depletes cholesterol from
the cell membrane, was added (data not shown).
Next, transmission electron microscopy offered an additional
perspective of the effects caused by macrophage ABCA2 deficiency,
particularly on the intracellular storage/trafficking of oxLDL-
derived lipids (Fig. 5). Lipid-laden WT macrophages showed the
occurrence of endosomal/lysosomal-like vesicles, whereas its
presence was low in ABCA2-deficient cells. Instead, ABCA2-
deficient macrophages exhibited cytoplasms filled with lipid
droplets (Fig. 5). The foam cells in the aortic arch of ABCA2-
transplanted animals showed more widespread lipid accumula-
tion (Fig. 6). Consequently, the size of the macrophages in the
atherosclerotic lesions was increased (Supplementary Fig. VIII).
Fig. 4. Effect of macrophage ABCA2 deficiency on lipid deposits in BM-derived macrophages upon oxLDL exposure. WT and ABCA2 KO BM-derived macrophages were incubated in
serum free control medium or supplemented with oxLDL (20 mg/mL) for 24 h. Fluorescence photomicrographs of filipin-stained FC (A) and LipidTOX staining for neutral sterols (B),
and graphs show the quantitation of the image analysis (#vesicles/nuclei). Inset, fluorescent phospholipid staining for all conditions. Values represent the mean  SEM. Statistically
significant difference **P < 0.01. Bar, 10 mm.
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In the present study, we have shown that the absence of
leukocyte ABCA2 results in smaller atherosclerotic lesions in LDLr
deficient mice accompanied with and/or caused by increased
apoptosis. Furthermore, our results support a role for ABCA2 in
intracellular lipid trafficking/distribution in macrophages consis-
tent with its lysosomal sequestering role, rather than having
a direct impact on cholesterol efflux.
Atherosclerosis is characterized by inflammation and choles-
terol deposition in the arterial wall. Oxidation of LDL accompanies
the disease process and oxidized lipoproteins are indeed present
in vivo, particularly in arterial lesions [28]. Excess cholesterol ester
accumulation in macrophages of the vessel occurs as a result of an
imbalance between delivery and removal and leads to formation of
lipid-laden foam cells. Macrophages are incapable of limiting the
uptake of lipids via scavenger receptors and, therefore, largely
depend on cholesterol efflux pathways to maintain cellular lipid
homeostasis, mainly through ATP-binding cassette transporters.
Among them, ABCA1 appears to be crucial for cellular cholesterol
and phospholipids efflux to lipid-poor apoA-I [22,23] and, inter-
estingly, ABCA2 is a close relative [9]. However, there is only limited
information available to date on the function of ABCA2 in macro-
phages, where this transporter is abundantly expressed [7]. The
goal of the present study was to test whether ABCA2 contributes to
the regulation of macrophage sterol homeostasis in the vessel wall
and modulates the susceptibility to atherosclerosis. We examined
the effect of ABCA2 deficiency on lipid metabolism in BM-derived
macrophages and on atherogenesis in LDLr-deficient mice, an
established model for atherosclerosis studies.We found that loss of ABCA2 function in macrophages disturbed
lipid homeostasis by affecting the intracellular lipid distribution.
Control and oxLDL-laden ABCA2 KO cells mostly exhibited a diffuse
FC distribution over peripheral regions, probably in internal
membranes and/or coupled to cytosolic carriers [29]. However,
discrete fluorescent filipin-positive droplets were clearly observed
in WT cells. It has been shown that in macrophages the FC gener-
ated from the hydrolysis of oxLDL cholesteryl esters is trapped in
the lysosomes [30]. The lysosomal cholesterol enrichment coin-
cides with a reduction in acid sphingomyelinase activity, which is
inhibited by 7-ketocholesterol present in oxLDL, leading to lyso-
somal accumulation of sphingomyelin (SM)which traps the FC [31].
Accordingly, abundant lysosome-like compartments were
observed in oxLDL-ladenWT macrophages by electron microscopy.
In this regard, reduced SM content has been described in ABCA2-
null brain [14], though the concentration of SM species deter-
mined by liquid chromatography/mass spectrometry analysis did
not differ significantly between WT and ABCA2 KO cells in our
study (P > 0.3 for all species; data not shown) or in CNS tissue of
WT and ABCA2 KO littermates [15].
Interestingly, a higher occurrence of discrete cytoplasmic
neutral sterol droplets was quantified in ABCA2 KOmacrophages as
compared to WT cells, what was confirmed by ultrastructural
microscopy. ABCA2 localizes to a variety of cellular compartments
fundamental for intracellular cholesterol dynamics, primarily the
endolysosomal and trans-Golgi membranes network [32].
Presumably, ABCA2 may facilitate FC uptake/storage into peri-
nuclear vesicles, which transport a variety of substrates across
intracellular membranes for vectorial transfer or ultimate fusion
with a membrane destination, similarly to other ATP-dependent
Fig. 5. Effect of macrophage ABCA2 deficiency on conventional transmission electron microscopy of macrophages lipid laden by treatment with oxLDL for 24 h. WT macrophages
showed abundant cytoplasmic vesicular endosomal/lysosomal-like compartments (Ly), whereas ABCA2 KO cells contained rich accumulations of lipid droplets (LD). Original
magnification 6000.
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constitutive overexpression of ABCA2 protein in CHO and neuro-
blastoma cells impaired the delivery of LDL-derived FC to the
endoplasmic reticulum for esterification and resulted in cholesterol
sequestration in lysosomes [19,21]. Our data are in agreement with
this lysosomal oriented sequestration role of ABCA2.
The comparable relative cholesteroldistributionofoxLDL-loaded
cells and control cells (no added lipoproteins) might indicate that
under these latter conditions a similar intracellular route for
cholesterol transport is utilized as with oxLDL loaded cells. Inter-
estingly, the widespread fluorescent filipinesterol complexes and
the higher occurrence of neutral sterol lipid droplets in ABCA2-
deficient macrophages did not affect quantitatively the total
cholesterol content (sum of FC and cholesteryl esters (CE)) detectedFig. 6. Effect of macrophage ABCA2 deficiency on foam cell formation in the atherosclerotic l
marrow from WT and ABCA2 KO mice was visualized by conventional transmission electroby the cholesterol oxidasemethod in oxLDL-laden cells. In the same
line, leukocyte ABCA2 deficiency did notmodify the lipid staining in
organswith high prevalence of macrophages, which correlates with
unaffected central nervous system tissue lipid composition in
ABCA2 total deficient mice [15]. Therefore, ABCA2 loss seems to
dysregulate cholesterol distribution/localization, whereas overall
lipid concentrations are unchanged. Previous data showed that
ABCA2 expression is coordinately regulated with genes whose
expression responds to changes in cellular cholesterol availability
[19]. Thus, overexpression of ABCA2 positively regulated sterol-
responsive genes which are elevated under sterol-deprived condi-
tions in CHO and neuroblastoma cells [19,21]. Accordingly, in the
current study,ABCA2deficiency in lipid-ladenmacrophages showed
downregulation of the rate limiting enzyme for cholesterogenesis,esions. Foam cell formation in the aorta arch from LDLr KO mice transplanted with bone
n microscopy. 5 mm-long ruler was inserted in the picture.
L. Calpe-Berdiel et al. / Atherosclerosis 223 (2012) 332e341340HMG-CoA reductase. The trend to reduced SREBP2 gene expression
in these cells might have contributed to the downregulation of
HMG-CoA reductase [35]. Of note, the proximal promoter of the
ABCA2 gene contains binding sites for the Sp1 transcription factor
[12]. In this regard, a 2-fold reduction in the Sp1 gene expression,
which also controls SREBP2 transcription,wasdetected inABCA2KO
macrophages as compared to WT controls.
The elucidation of the role of macrophage ABCA2 in athero-
genesis is important, not only for its relatedness to ABCA1 but also
for its impact on intracellular cholesterol homeostasis and traf-
ficking. Actually, recent data demonstrate that abnormalities in
cellular cholesterol trafficking, for instance loss of Niemann-Pick C1
(NPC1) function in BM-derived cells, can directly modulate
atherosclerosis susceptibility [36]. Absence of ABCA2 in leukocytes
reduced atherosclerosis development in LDLr KO mice in the aortic
root (24.5%) and the thoracic aorta (36.6%). It has previously
been suggested that the ABCA2 transporter may have a role in
cholesterol efflux, as it is a cholesterol-responsive gene with highly
conserved identity in a C-terminal region associated with the
ABCA1-apoA-I interaction and lipid efflux [7,37]. However, analo-
gous efflux rates to apoA-I and HDL were observed between single
ABCA1 and combined ABCA1/ABCA2 deficiency indicating that
defective ABCA2 did not have measurable effects on this parameter
in macrophages, at least not in the currently employed assays. In
line, a lack of impact of transient ABCA2 expression on either
cholesterol efflux and Ab peptide secretion in CHO cells, or
cholesterol efflux to apoE discs in neuronal cell lines has been
previously described [38]. In the same line, it is unlikely that ABCA1
upregulation is the primary cause for the decreased atherosclerosis
susceptibility of ABCA2 KO transplanted animals as no effects on
cellular cholesterol efflux were observed. However, ABCA2 may
interact with intracellular ABCA1 in cholesterol transport as sug-
gested by Ouimet and Marcel [39]. In paticular, the shuttling of
ABCA1 for the efflux of cholesterol out of endosomal compartments
maybe functionally important. Furthermore, macrophage ABCA1
overexpression does not affect on the development of initial lesions
and only inhibits lesion progression in later stages in LDLr KO mice
(9 weeks on high fat diet) [40].
Apoptosis plays an important role in the development of
atherosclerotic lesions [41,42]. Interestingly, an increase in macro-
phage apoptosis in early lesions has been associatedwith decreased
lesion progression [41], while in advanced lesions apoptosis does
lead to larger lesions [43]. Caspase-dependent apoptosis was
significantly increased in lesions of recipient mice that had
undergone transplantation with bone marrow from ABCA2 KO
mice. The observed increase in apoptosis might account for rela-
tively a fewer number of larger macrophages in atherosclerotic
lesions of ABCA2 KO transplanted animals. Furthermore, based on
our in vitro studies, we conclude that ABCA2 deficient macrophages
are more prone than WT cells to undergo apoptosis in response to
oxidative lipids. Oxidative lipids exert a clear stimulation of
autophagy and apoptosis [39]. Thus, inactive ABCA2 might increase
cell death due to abnormalities in lipid distribution and trafficking
through the lysosomal pathway, presumably, as a result of the
broad distribution of unesterified FC, which is known to stimulate
proapoptotic processes [44,45]. A different way of cholesterol
accumulation inside the cell may help uncover the specific role of
ABCA2 in the prevention of apoptosis more clearly. Direct transport
studies with fluorescent lipids in ABCA2 KO macrophages will be
needed to investigate the relation between intracellular cholesteorl
deposition and apoptosis in the future.
In conclusion, the current study suggests that macrophage
ABCA2 deletion modulates intracellular cholesterol distribution/
trafficking, leading to increased susceptibility to apoptosis and
reduced development of early atherosclerotic lesions.Sources of funding
This workwas supported by the Catalan University and Research
GrantsManagement Agency (Beatriu de Pinós Postdoctoral Grant to
LC-B), by the Netherlands Heart Foundation (Grants 2007T056 to D.
Y., 2001T4101 to Y.Z.), by the Netherlands Organization for Scien-
tific Research (VIDI Grant 917.66.301 toM.V.E.), and by Top Institute
Pharma (TIPharma project T2-110). This project was done under the
framework of Top institute Pharma T2-110, with Partners MSD,
Radboud University Nijmegen, University medical Center Gronin-
gen, University of Leiden, the AcademicMedical Center Amsterdam,
and TI Pharma. M. Van Eck is an Established Investigator of the




We are grateful to Cristina Avramut and Jos Onderwater for
technical assistance with electron microscopy (LUMC, Dept. of
Molecular Cell Biology), to Dr. Raimond Ravelli for electron
microscopy imaging (LUMC, Dept. of Molecular Cell Biology), to Dr.
Adrie Dane for statistical assistance (LACDR, Division of Analytical
Biosciences), to Leah Winkel and Hans de Bont for fluorescence
imaging assistance (LACDR, Division of Toxicology), and to Lin He
for support with ABCA2 KOmice breedings (MUSC, Dept. of Cell and
Molecular Pharmacology and Experimental Therapeutics).
Appendix A. Supplementary material
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.atherosclerosis.
2012.05.039.
References
[1] Dean M, Hamon Y, Chimini G. The human ATP-binding cassette (ABC) trans-
porter superfamily. J Lipid Res 2001;42:1007e17.
[2] Schmitz G, Kaminski WE, Orso E. ABC transporters in cellular lipid trafficking.
Curr Opin Lipidol 2000;11:493e501.
[3] Schmitz G, Kaminski WE. ATP-binding cassette (ABC) transporters in athero-
sclerosis. Curr Atheroscler Rep 2002;4:243e51.
[4] Remaley AT, Stonik JA, Demosky SJ, et al. Apolipoprotein specificity for lipid
efflux by the human ABCAI transporter. Biochem Biophys Res Commun 2001;
280:818e23.
[5] Out R, Hoekstra M, Hildebrand RB, et al. Macrophage ABCG1 deletion disrupts
lipid homeostasis in alveolar macrophages and moderately influences
atherosclerotic lesion development in LDL receptor-deficient mice. Arte-
rioscler Thromb Vasc Biol 2006;26:2295e300.
[6] Pennings M, Hildebrand RB, Ye D, et al. Bone marrow-derived multidrug
resistance protein ABCB4 protects against atherosclerotic lesion development
in LDL receptor knockout mice. Cardiovasc Res 2007;76:175e83.
[7] Kaminski WE, Piehler A, Pullmann K, et al. Complete coding sequence,
promoter region, and genomic structure of the human ABCA2 gene and
evidence for sterol-dependent regulation in macrophages. Biochem Biophys
Res Commun 2001;281:249e58.
[8] Mack JT, Townsend DM, Beljanski V, Tew KD. The ABCA2 transporter: intra-
cellular roles in trafficking and metabolism of LDL-derived cholesterol and
sterol-related compounds. Curr Drug Metab 2007;8:47e57.
[9] Luciani MF, Denizot F, Savary S, Mattei MG, Chimini G. Cloning of two novel
ABC transporters mapping on human chromosome 9. Genomics 1994;21:
150e9.
[10] Tenen DG, Hromas R, Licht JD, Zhang DE. Transcription factors, normal
myeloid development, and leukemia. Blood 1997;90:489e519.
[11] Schmitz G, Kaminski WE. ABCA2: a candidate regulator of neural trans-
membrane lipid transport. Cell Mol Life Sci 2002;59:1285e95.
[12] Vulevic B, Chen Z, Boyd JT, et al. Cloning and characterization of human
adenosine 5’-triphosphate-binding cassette, sub-family A, transporter 2
(ABCA2). Cancer Res 2001;61:3339e47.
[13] Flower DR, North AC, Attwood TK. Structure and sequence relationships in the
lipocalins and related proteins. Protein Sci 1993;2:753e61.
L. Calpe-Berdiel et al. / Atherosclerosis 223 (2012) 332e341 341[14] Sakai H, Tanaka Y, Tanaka M, et al. ABCA2 deficiency results in abnormal
sphingolipid metabolism in mouse brain. J Biol Chem 2007;282:19692e9.
[15] Mack JT, Beljanski V, Soulika AM, et al. “Skittish” Abca2 knockout mice display
tremor, hyperactivity, and abnormal myelin ultrastructure in the central
nervous system. Mol Cell Biol 2007;27:44e53.
[16] Zhou C, Zhao L, Inagaki N, et al. Atp-binding cassette transporter ABC2/ABCA2
in the rat brain: a novel mammalian lysosome-associated membrane protein
and a specific marker for oligodendrocytes but not for myelin sheaths.
J Neurosci 2001;21:849e57.
[17] Langmann T, Klucken J, Reil M, et al. Molecular cloning of the human ATP-
binding cassette transporter 1 (hABC1): evidence for sterol-dependent regu-
lation in macrophages. Biochem Biophys Res Commun 1999;257:29e33.
[18] Klucken J, Buchler C, Orso E, et al. ABCG1 (ABC8), the human homolog of the
Drosophila white gene, is a regulator of macrophage cholesterol and phos-
pholipid transport. Proc Natl Acad Sci U S A 2000;97:817e22.
[19] Davis Jr W, Boyd JT, Ile KE, Tew KD. Human ATP-binding cassette transporter-
2 (ABCA2) positively regulates low-density lipoprotein receptor expression
and negatively regulates cholesterol esterification in Chinese hamster ovary
cells. Biochim Biophys Acta 2004;1683:89e100.
[20] Mack JT, Beljanski V, Tew KD, Townsend DM. The ATP-binding cassette
transporter ABCA2 as a mediator of intracellular trafficking. Biomed Phar-
macother 2006;60:587e92.
[21] Davis Jr W. The ATP-binding cassette transporter-2 (ABCA2) regulates
cholesterol homeostasis and low-density lipoprotein receptor metabolism in
N2a neuroblastoma cells. Biochim Biophys Acta 2011.
[22] van Eck M, Bos IS, Kaminski WE, et al. Leukocyte ABCA1 controls susceptibility
to atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad
Sci U S A 2002;99:6298e303.
[23] Aiello RJ, Brees D, Bourassa PA, et al. Increased atherosclerosis in hyper-
lipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler
Thromb Vasc Biol 2002;22:630e7.
[24] Wellington CL, Brunham LR, Zhou S, et al. Alterations of plasma lipids in mice
via adenoviral-mediated hepatic overexpression of human ABCA1. J Lipid Res
2003;44:1470e80.
[25] Hara A, Radin NS. Lipid extraction of tissues with a low-toxicity solvent. Anal
Biochem 1978;90:420e6.
[26] Griffin EE, Ullery JC, Cox BE, Jerome WG. Aggregated LDL and lipid dispersions
induce lysosomal cholesteryl ester accumulation in macrophage foam cells.
J Lipid Res 2005;46:2052e60.
[27] Schmitz G, Grandl M. Endolysosomal phospholipidosis and cytosolic lipid
droplet storage and release in macrophages. Biochim Biophys Acta 2009;
1791:524e39.
[28] Lusis AJ. Atherosclerosis. Nature 2000;407:233e41.
[29] Maxfield FR, Wustner D. Intracellular cholesterol transport. J Clin Invest 2002;
110:891e8.
[30] Maor I, Aviram M. Oxidized low density lipoprotein leads to macrophage
accumulation of unesterified cholesterol as a result of lysosomal trapping of
the lipoprotein hydrolyzed cholesteryl ester. J Lipid Res 1994;35:803e19.[31] Maor I, Mandel H, Aviram M. Macrophage uptake of oxidized LDL inhibits
lysosomal sphingomyelinase, thus causing the accumulation of unesteri-
fied cholesterol-sphingomyelin-rich particles in the lysosomes. A possible
role for 7-Ketocholesterol. Arterioscler Thromb Vasc Biol 1995;15:
1378e87.
[32] Ile KE, Davis Jr W, Boyd JT, Soulika AM, Tew KD. Identification of a novel first
exon of the human ABCA2 transporter gene encoding a unique N-terminus.
Biochim Biophys Acta 2004;1678:22e32.
[33] Matsumura Y, Sakai H, Sasaki M, Ban N, Inagaki N. ABCA3-mediated choline-
phospholipids uptake into intracellular vesicles in A549 cells. FEBS Lett 2007;
581:3139e44.
[34] Akiyama M, Sugiyama-Nakagiri Y, Sakai K, et al. Mutations in lipid transporter
ABCA12 in harlequin ichthyosis and functional recovery by corrective gene
transfer. J Clin Invest 2005;115:1777e84.
[35] Horton JD, Shimomura I, Brown MS, Hammer RE, Goldstein JL, Shimano H.
Activation of cholesterol synthesis in preference to fatty acid synthesis in liver
and adipose tissue of transgenic mice overproducing sterol regulatory
element-binding protein-2. J Clin Invest 1998;101:2331e9.
[36] Zhang JR, Coleman T, Langmade SJ, et al. Niemann-Pick C1 protects against
atherosclerosis in mice via regulation of macrophage intracellular cholesterol
trafficking. J Clin Invest 2008;118:2281e90.
[37] Fitzgerald ML, Okuhira K, Short 3rd GF, Manning JJ, Bell SA, Freeman MW.
ATP-binding cassette transporter A1 contains a novel C-terminal VFVNFA
motif that is required for its cholesterol efflux and ApoA-I binding activities.
J Biol Chem 2004;279:48477e85.
[38] Kim WS, Rahmanto AS, Kamili A, et al. Role of ABCG1 and ABCA1 in regulation
of neuronal cholesterol efflux to apolipoprotein E discs and suppression of
amyloid-beta peptide generation. J Biol Chem 2007;282:2851e61.
[39] Ouimet M, Marcel YL. Regulation of lipid droplet cholesterol efflux from
macrophage foam cells. Arterioscler Thromb Vasc Biol 2012;32(3):
575e81.
[40] Van Eck M, Singaraja RR, Ye D, et al. Macrophage ATP-binding cassette
transporter A1 overexpression inhibits atherosclerotic lesion progression in
low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc
Biol 2006;26:929e34.
[41] Arai S, Shelton JM, Chen M, et al. A role for the apoptosis inhibitory factor AIM/
Spalpha/Api6 in atherosclerosis development. Cell Metab 2005;1:201e13.
[42] Tabas I. Consequences and therapeutic implications of macrophage apoptosis
in atherosclerosis: the importance of lesion stage and phagocytic efficiency.
Arterioscler Thromb Vasc Biol 2005;25:2255e64.
[43] Shearn AI, Deswaerte V, Gautier EL, et al. Bcl-x inactivation in macrophages
accelerates progression of advanced atherosclerotic lesions in Apoe-/- mice.
Arterioscler Thromb Vasc Biol 2012;32(5):1142e9.
[44] Tabas I. Consequences of cellular cholesterol accumulation: basic concepts
and physiological implications. J Clin Invest 2002;110:905e11.
[45] Feng B, Yao PM, Li Y, et al. The endoplasmic reticulum is the site of
cholesterol-induced cytotoxicity in macrophages. Nat Cell Biol 2003;5:
781e92.
